Covetrus Announces Fourth Quarter and Full-Year 2020 Earnings Release Date and Conference Call Information – About Your Online Magazine

PORTLAND, Maine – () –Covetrus (NASDAQ: CVET), a global leader in animal health technology and services, announced today that it will release its fourth quarter and 2020 results on the morning of Monday, March 1, 2021. After the launch, the Company will hold a conference call on 8:30 ET, during which Covetrus President and Chief Executive Officer Benjamin Wolin and Executive Vice President and Chief Financial Officer Matthew Foulston will review the results for the fourth quarter and full year 2020.

To access the live webcast of the conference call, individuals can visit the Investor Relations page of the Covetrus website: An archived edition of the results conference call will also be posted on Covetrus’ website later that day and will remain available to interested parties through the same link for one year.

The conference call can also be accessed by dialing 866-789-2492 for US / Canada participants, or 409-937-8901 for international participants and referencing confirmation code 7699826. A repeat of the conference call will be available for two weeks until March 15, 2021 by dialing 855-859-2056 or 404-537-3406. The reproduction confirmation code is 7699826.

About Covetrus

Covetrus is a global animal health technology and services company dedicated to empowering veterinary practice partners to drive better financial and health outcomes. We are bringing together products, services and technology on a single platform that connects our customers to the solutions and insights they need to work better. Our passion for the welfare of animals and those who care for them leads us to advance in the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving more than 100,000 customers worldwide. For more information about Covetrus visit

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and which involve risks and uncertainties, including statements about our plans, objectives, expectations and intentions. These statements are subject to several risks and uncertainties. Factors that could adversely affect our business and prospects are presented in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on the current beliefs and expectations of our management team and, except as required by law, we undertake no obligation to revise the forward-looking statements contained in this release or update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

Paula Fonseca